ARCHIVES

FDA Allows Firms To Distribute Reprints On Unapproved Uses of Products

This article is from The Cancer Letter archive.

Vol. 35 No. 02 | January 16, 2009

Download PDF Visit The Full Archive

Related Articles

Phase II Study Tests Chemo Plus Mylotarg For AML

December 27, 2002

In Brief: Hatch Restores NCI Budget Bypass Authority In His Bill Renewing National Cancer Act

April 23, 1982

Addendum to RAID

December 17, 1999

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

In Brief: Last Two NCAB Choices Named; Hellman Heads ASCO, Sartorelli Named President Of AACR

May 16, 1986

Breast Density As Important As Age In Determining Risk

September 29, 2006